Karuna Therapeutics, Inc.

Ownership Transactions Reported by 16 Insiders

Industry
Pharmaceutical Preparations
Location
99 High Street, 26 Th Floor, Boston, MA

Insiders trading volume in the past year

Karuna Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Troy A. Ignelzi Chief Financial Officer $18.3M Aug 22, 2023
Charmaine Lykins Chief Commercial Officer $6.92M Nov 29, 2021
Heather Preston Director $2.86M Jun 24, 2021
David Wheadon Director $0 Mar 18, 2024
Laurie J. Olson Director $0 Mar 18, 2024
William P. Kane Jr Chief Commercial Officer $0 Mar 18, 2024
Andrew Craig Miller President of R&D $0 Mar 18, 2024
James Healy Director $0 Mar 18, 2024
Atul Pande Director $0 Mar 18, 2024
William Meury President and CEO, Director $0 Mar 18, 2024
Christopher J. Coughlin Director $0 Mar 18, 2024
Stephen K. Brannan Chief Medical Officer $0 -$10.8M -100% Mar 18, 2024
Steven M. Paul Director $0 Mar 18, 2024
Jason Brown Chief Financial Officer $0 Mar 18, 2024
Denice Torres Director $0 Mar 18, 2024
Jeffrey M. Jonas Director $0 Mar 15, 2024

Recent Insider Transactions by Companies or Individuals for Karuna Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.